Data from multiple sources - Curated by EPG Health - Last updated 06 June 2017

Latest news articles

Added 3 days ago Drug news

FDA accepts supplemental application to expand indication of Cinryze to children aged 6 years and older with hereditary angioedema.- Shire.

The FDA has accepted the Cinryze (C1 esterase inhibitor [human]), from Shire, supplemental Biologics License Application (sBLA) to expand the...

Added 5 months ago Drug news

Phase III SAHARA study success for SHP 616 Liquid (subcutaneously administered C1 esterase inhibitor [human] Liquid for Injection) to treat Hereditary Angioedema.-Shire plc.

Shire plc announces positive topline Phase III results for the SAHARA study, a global, multi-center, randomized, double-blind, placebo-controlled, partial crossover...

Added 7 months ago Drug news

FDA approves Haegarda (subcutaneous C1-esterase inhibitor) for subcutaneous administration to prevent hereditary angioedema (HAE) attacks in adolescent and adult patients.-CSL Behring

The FDA has approved Haegarda, the first C1 Esterase Inhibitor (Human) for subcutaneous (under the skin) administration to prevent Hereditary...

Search all news articles for Immunity disorders

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Inflammatory Bowel Disease Knowledge Centre

Inflammatory Bowel Disease Knowledge Centre

The Inflammatory Bowel Disease (IBD) Knowledge Centre contains key information relating to the epidemiology and pathophysiology of Crohn’s disease and ulcerative colitis, highlighting prevalence, impact and unmet needs and the underlying inflammatory processes that drive IBD, considering some of the key inflammatory pathways.

Chronic Spontaneous Urticaria (CSU)

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria

+ 7 more

Load more


ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

This part of the European Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases...

Added 5 years ago

Search all guidelines for Immunity disorders

Journal articles

Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection.

Rituximab, a monoclonal antibody that targets CD20 on B cells, is now central to the treatment of a variety of malignant and autoimmune disorders.

Added 8 months ago

Human immunoglobulin 10 % with recombinant human hyaluronidase: replacement therapy in patients with primary immunodeficiency disorders

Human immunoglobulin is an established replacement therapy for patients with primary immunodeficiency disorders (PIDs). Recombinant human hyaluronidase (rHuPH20) is a...

Added 3 years ago

Risk factors for oral mucositis in children receiving hematopoietic cell transplantation for primary immunodeficiencies: A retrospective study

OM is a frequent complication for patients undergoing HSCT. The aim of this study was to evaluate the possible risk...

Added 4 years ago

Search all journal articles for Immunity disorders